Renaissance of “food as medicine” in modern clinical trials

Priya Venkatesan discusses in Nature Medicine how dietary interventions can prevent or delay diseases, highlighting the reemergence of “food as medicine” in modern clinical trials.

Boosting endocannabinoids could reduce opioid addiction risk

Increasing the levels of chemicals naturally produced in the body called endocannabinoids may thwart the highly addictive nature of opioids such as morphine and oxycodone

December 2, 2024

Sensorion raises $16m for gene therapies to treat deafness – Pharmaceutical Technology

Share this article Mutations in the otoferlin protein are a frequent cause of deafness in children. Image credit: Shutterstock/CC7. Sensorion has secured €14.8m ($16m) from

April 8, 2024

Stealth BioTherapeutics CEO discusses surprise adcomm support for ultra-rare disease drug

This week, Stealth BioTherapeutics CEO Reenie McCarthy faced a seemingly insurmountable roadblock with the company’s drug for the ultra-rare, fatal mitochondrial disease Barth syndrome. FDA

October 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.